Latest Immunosuppressive drug Stories
For the thousands of patients who receive kidney transplants in the United States each year, preventing organ rejection without compromising other aspects of health requires a delicate balance of medications.
PRINCETON, N.J., July 28, 2011 /PRNewswire/ -- Soligenix, Inc. (Soligenix or the Company) (OTC BB: SNGX), a late-stage biopharmaceutical company, announces the expansion and amendment of its North American licensing partnership with Sigma-Tau Pharmaceuticals, Inc.
ATLANTA, July 25, 2011 /PRNewswire/ -- Waters Corporation (NYSE: WAT) today announced that its MassTrak(TM) Immunosuppressants XE Kit is now CE-marked in accordance with the IVD Directive 98/79/EC, for the quantitative measurement of the immunosuppressive drugs tacrolimus (FK506;PrografÂ®) in liver and kidney transplant patients and everolimus (CerticanÂ®) in adult kidney and cardiac transplant patients from human whole blood samples as an aid in the management of immunosuppressant drug...
PRAGUE, June 25, 2011 /PRNewswire/ -- The SHARP-study has shown that lowering LDL cholesterol with ezetimibe/simvastatinleads to a significant reduction in major atherosclerotic events among CKD-patients.
Cells found naturally in the body may help prevent the rejection of an organ transplant. Research shows new cell therapy could also eliminate a transplant patientâ€™s need for life-long medication and could help their transplant last longer.
Researchers at King's College London have used cells found naturally in the body, to re-educate the immune system to prevent rejection of an organ transplant while remaining capable of fighting infections and cancer.
Spanish researchers have found that liver transplant recipients who quit smoking have a lower incidence of smoking-related malignancies (SRM) than patients who keep smoking.
Researchers from Cleveland Clinic's Lerner Research Institute have discovered that resveratrol â€“ a compound found in red wine â€“ when combined with rapamycin can have a tumor-suppressing effect on breast cancer cells that are resistant to rapamycin alone.
Today, individuals with lupus nephritis benefit from better treatments than a decade ago.
PRINCETON, N.J., Oct. 25 /PRNewswire-FirstCall/ -- Soligenix, Inc.
- A woman chauffeur.
- A woman who operates an automobile.